Consider a GLP-1 Agonist for Diabetic Patients on 2 or 3 Oral Meds

August 2014

Tanzeum (TAN-zee-um, albiglutide) will be another GLP-1 agonist for diabetes...after Byetta, Victoza, and Bydureon.

Help pick one based on their pros and cons...and patient preference.

A1C lowering is about 1% with Tanzeum or Byetta (exenatide)... 1.3% with Bydureon (exenatide ER)...and 1.5% with Victoza (liraglutide).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Practice Help Tackle Common Med Issues With Comprehensive Medication Reviews
Measles Identify Patients Who Could Benefit From Measles Vaccination
Infectious Diseases Watch For NEW Antibiotics for Skin Infections
Diabetes Consider a GLP-1 Agonist for Diabetic Patients on 2 or 3 Oral Meds
Pediatrics Encourage Prescribers to Include Notes on Kids' Quinolone Rxs
Benzodiazepines Explain How to Taper Off Benzodiazepines
Fungal Infections Suggest Topical Jublia for Patients Who Can't Use Oral Terbinafine
Neurology & Pain Recommend Testing for Patients With Memory Loss
Sleep Disorders Avoid Sedatives With Sleep Apnea
Opioids Alert Patients About Changes to Their Tramadol Rxs
Diabetes Watch for Avandia Rxs...Again
Infectious Diseases Consider New Antibiotics After Treatment Failure for MRSA Skin Infections
Cardiology Discourage Using the New Oral Antiplatelet Drug Zontivity Alone
Antiepileptics Watch for Three New Antiepileptics
Practice Caution Patients About Flammable Meds
Infectious Diseases Help Avoid Serious Interactions With Long-Term Antibiotics